Iovance Biotherapeutics
IOVA
$11.64
Share price
0.87%
Change (1 day)
112.80%
Change (1 year)
Categories
Market capitalization of Iovance Biotherapeutics (IOVA)
Market cap: $3.25 Billion
As of April 2024 Iovance Biotherapeutics has a market cap of $3.25 Billion. This makes Iovance Biotherapeutics the world's 3307th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Iovance Biotherapeutics from 2010 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.25 B | 56.26% |
| 2023 | $2.08 B | 106.34% |
| 2022 | $1.00 B | -66.33% |
| 2021 | $2.99 B | -55.99% |
| 2020 | $6.80 B | 94.52% |
| 2019 | $3.49 B | 220.36% |
| 2018 | $1.09 B | 87.97% |
| 2017 | $0.58 B | 34.41% |
| 2016 | $0.43 B | 15.34% |
| 2015 | $0.37 B | 41.1% |
| 2014 | $0.26 B | 26.33% |
| 2013 | $0.21 B | 1073.04% |
| 2012 | $17.92 M | -77.31% |
| 2011 | $78.99 M | -10.61% |
| 2010 | $88.36 M |
End of Day market cap according to different sources
On Apr 26th, 2024 the market cap of Iovance Biotherapeutics was reported to be:
$3.25 Billion
$3.25 Billion
$3.25 Billion
$3.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $18.25 M | -99.44% | Bahamas |
 NRC Health
NRC | $0.80 B | -75.17% | 🇺🇸 USA |